ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2013

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

10,440Medicare Part D Prescriptions Filled, Including Refills

Rank: 534 out of 2087

$828K Total Retail Price of All Prescriptions

Rank: 297 out of 2087

481 Patients Receiving at Least One Drug in Part D
92% Patients 65 Years and Older
10% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg 81928cdb0ebe162ff75cf405bfacadd396bf3ec84bc467b6f3e612dd63daa776 Average for
this specialty
in Ohio
Lower avg 72b1978e1dcc0b845f89d17d692cfff7aeaf8d8bce70310d8bfc535db2daf62a

Schedule Two
Controlled Substances

4% of this provider’s 481 patients filled at least one prescription for a schedule two drug, compared to an average of 5%.

Schedule Three
Controlled Substances

6% of this provider’s 481 patients filled at least one prescription for a schedule three drug, compared to an average of 8%.

Brand Name Drugs

23% of this provider’s prescriptions were for brand-name drugs, compared to an average of 22%.

Prescription Price

$79 was the average price of a prescription from this provider, compared to $60 among peers.

Prescriptions per Patient

22 is the average number of prescriptions (including refills) per patient, compared to an average of 20.


This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

B

A benzodiazepine, or tranquilizer. More » The American Geriatrics Society says these drugs increase the risk of cognitive impairment, delirium, falls and fractures in older adults.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled with Refills Prescriptions
to 65+
Patients Recieving this Drug Category For this Prescriber For All Prescribers in
This Specialty in Ohio
AMLODIPINE BESYLATE 491 465 98 1 4
ATORVASTATIN CALCIUM 462 448 108 2 6
LISINOPRIL 431 407 92 3 1
LEVOTHYROXINE SODIUM 430 402 88 4 2
SIMVASTATIN 408 386 93 5 3
OMEPRAZOLE 345 333 73 6 5
AMLODIPINE BESYLATE-BENAZEPRIL 232 216 48 7 88
FUROSEMIDE 212 207* 50 8 7
TAMSULOSIN HCL 184 179* 37 9 28
ATENOLOL 181 167 38 10 16
LOSARTAN POTASSIUM 179 153 35 11 15
LISINOPRIL-HYDROCHLOROTHIAZIDE 165 165 38 12 29
EVISTA 147 142* 36 13 147
ZOLPIDEM TARTRATE 145 131 30 14 31
NAMENDA 139 139 23 15 30
HYDROCHLOROTHIAZIDE 129 115 28 16 11
CARVEDILOL 124 111 28 17 23
MELOXICAM 122 117* 40 18 44
LORAZEPAM 112 101 33 B 19 25
HYDROCODONE-ACETAMINOPHEN 102 91 28 S3 20 10
ALLOPURINOL 101 96* 24 21 27
EXELON 99 99 19 22 99
CITALOPRAM HBR 98 93* 24 23 21
VENLAFAXINE HCL ER 94 77 24 24 97
DOXAZOSIN MESYLATE 93 88* 20 25 82
METOPROLOL SUCCINATE 93 88* 24 25 20
METOPROLOL TARTRATE 92 87* 23 27 8
CRESTOR 92 78 18 27 36
METFORMIN HCL 92 87* 27 27 9
POTASSIUM CHLORIDE 91 86* 19 30 17
CLOPIDOGREL 87 87 19 31 18
OXYBUTYNIN CHLORIDE ER 85 85 19 32 77
FLUOXETINE HCL 84 70 16 33 74
MIRTAZAPINE 82 71 16 34 49
TRAMADOL HCL-ACETAMINOPHEN 74 69* 20 35 191
ROPINIROLE HCL 74 <11 <11 35 94
MONTELUKAST SODIUM 72 72 15 37 53
NABUMETONE 71 66* 19 38 186
ADVAIR DISKUS 69 64* 20 39 63
PIOGLITAZONE HCL 66 66 12 R 40 96
CYMBALTA 61 61 17 41 51
METFORMIN HCL ER 61 56* 19 41 65
WARFARIN SODIUM 58 33 11 43 12
TRAMADOL HCL 58 45 15 43 19
LEVOFLOXACIN 58 53* 49 43 90
DONEPEZIL HCL 58 46 13 43 26
MECLIZINE HCL 57 52* 21 47 131
BUPROPION XL 56 51* 16 48 162
JANUVIA 56 51* 15 48 52
LOSARTAN-HYDROCHLOROTHIAZIDE 56 56 12 48 47
HYDRALAZINE HCL 56 56 13 48 69
PROAIR HFA 56 51* 22 48 40
SYNTHROID 55 55 13 53 54
PREDNISONE 54 49* 29 54 37
GABAPENTIN 50 50 13 55 14
ALENDRONATE SODIUM 50 <11 <11 55 35
About This Data

Prescribing data from Medicare’s prescription drug benefit, known as Part D, was compiled and released by the Centers for Medicare and Medicaid Services, the federal agency that oversees the program. ProPublica combined that data with additional information released by CMS. The data for 2013 includes nearly 1.4 billion prescriptions written by 1.3 million doctors, nurses and other providers. This database lists about 410,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths of these prescriptions went to patients 65 and older; the rest were for disabled patients Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to checkup@propublica.org and we will update your information. If you have other questions about this data, send a note to checkup@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on March 25, 2009.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.